
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques
Katherine McMahan, Frank Wegmann, Malika Aïd, et al.
Nature (2023) Vol. 626, Iss. 7998, pp. 385-391
Open Access | Times Cited: 40
Katherine McMahan, Frank Wegmann, Malika Aïd, et al.
Nature (2023) Vol. 626, Iss. 7998, pp. 385-391
Open Access | Times Cited: 40
Showing 1-25 of 40 citing articles:
Exploring new perspectives in immunology
Ruslan Medzhitov, Akiko Iwasaki
Cell (2024) Vol. 187, Iss. 9, pp. 2079-2094
Open Access | Times Cited: 16
Ruslan Medzhitov, Akiko Iwasaki
Cell (2024) Vol. 187, Iss. 9, pp. 2079-2094
Open Access | Times Cited: 16
Neutralization of SARS-CoV-2 Omicron subvariant BA.2.87.1
Ninaad Lasrado, Annika Rössler, Marjorie Rowe, et al.
Vaccine (2024) Vol. 42, Iss. 9, pp. 2117-2121
Open Access | Times Cited: 15
Ninaad Lasrado, Annika Rössler, Marjorie Rowe, et al.
Vaccine (2024) Vol. 42, Iss. 9, pp. 2117-2121
Open Access | Times Cited: 15
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants
Fábio Mambelli, Ana Carolina V. S. C. de Araujo, Jéssica Pires Farias, et al.
Pathogens (2025) Vol. 14, Iss. 1, pp. 23-23
Open Access | Times Cited: 1
Fábio Mambelli, Ana Carolina V. S. C. de Araujo, Jéssica Pires Farias, et al.
Pathogens (2025) Vol. 14, Iss. 1, pp. 23-23
Open Access | Times Cited: 1
COVID-19 vaccines: Immune correlates and clinical outcomes
Shant H. Mahrokhian, Lisa H. Tostanoski, Samuel J. Vidal, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Shant H. Mahrokhian, Lisa H. Tostanoski, Samuel J. Vidal, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 8
A SARS-CoV-2 mucosal nanovaccine based on assembly of maltodextrin, STING agonist and polyethyleneimine
Yu Tian, Liang Hu, Qingrui Huang, et al.
International Journal of Biological Macromolecules (2025), pp. 139395-139395
Closed Access
Yu Tian, Liang Hu, Qingrui Huang, et al.
International Journal of Biological Macromolecules (2025), pp. 139395-139395
Closed Access
Characterization of Vaccine-Enhanced Humoral Immune Responses Against Emergent SARS-CoV-2 Variants in a Convalescent Cohort
Jared Sheehan, Amber J. Trauth, Michael E. Hagensee, et al.
Pathogens (2025) Vol. 14, Iss. 1, pp. 44-44
Open Access
Jared Sheehan, Amber J. Trauth, Michael E. Hagensee, et al.
Pathogens (2025) Vol. 14, Iss. 1, pp. 44-44
Open Access
Lessons for Medical Countermeasure Development from Unforeseen Outbreaks
Marie Mura, Aurélie Trignol, E. Le Dault, et al.
Emerging Microbes & Infections (2025)
Open Access
Marie Mura, Aurélie Trignol, E. Le Dault, et al.
Emerging Microbes & Infections (2025)
Open Access
Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19
Durgesh Kumar, Kishor Gaikwad, Rushank Gunnale, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Durgesh Kumar, Kishor Gaikwad, Rushank Gunnale, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Immunobiology of COVID-19: Mechanistic and therapeutic insights from animal models
Hong‐Yi Zheng, Tian‐Zhang Song, Yong‐Tang Zheng
动物学研究 (2024) Vol. 45, Iss. 4, pp. 747-766
Open Access | Times Cited: 4
Hong‐Yi Zheng, Tian‐Zhang Song, Yong‐Tang Zheng
动物学研究 (2024) Vol. 45, Iss. 4, pp. 747-766
Open Access | Times Cited: 4
Durability of immune responses to SARS-CoV-2 infection and vaccination
Mehul S. Suthar
Seminars in Immunology (2024) Vol. 73, pp. 101884-101884
Closed Access | Times Cited: 4
Mehul S. Suthar
Seminars in Immunology (2024) Vol. 73, pp. 101884-101884
Closed Access | Times Cited: 4
Microfluidic Platform Enables Shearless Aerosolization of Lipid Nanoparticles for mRNA Inhalation
Jeonghwan Kim, Antony Jozić, Elissa Bloom, et al.
ACS Nano (2024) Vol. 18, Iss. 17, pp. 11335-11348
Closed Access | Times Cited: 3
Jeonghwan Kim, Antony Jozić, Elissa Bloom, et al.
ACS Nano (2024) Vol. 18, Iss. 17, pp. 11335-11348
Closed Access | Times Cited: 3
Plasmonic Nanograin Metasurface with Disorder‐Enhanced Biosensing for SARS‐CoV‐2 Variant and Antibodies
Fajun Li, Chaoheng Guan, Kaiyun Chen, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 36
Closed Access | Times Cited: 3
Fajun Li, Chaoheng Guan, Kaiyun Chen, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 36
Closed Access | Times Cited: 3
Beyond COVID-19: the promise of next-generation coronavirus vaccines
Reshma Koolaparambil Mukesh, Claude Kwe Yinda, Vincent J. Munster, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3
Reshma Koolaparambil Mukesh, Claude Kwe Yinda, Vincent J. Munster, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates
Matthew Gagné, Barbara J. Flynn, Shayne F. Andrew, et al.
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1913-1927
Open Access | Times Cited: 3
Matthew Gagné, Barbara J. Flynn, Shayne F. Andrew, et al.
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1913-1927
Open Access | Times Cited: 3
Early, robust mucosal secretory IgA but not IgG response to SARS-CoV-2 spike in oral fluid is associated with faster viral clearance and COVID-19 symptom resolution.
Nora Pisanic, Annukka A.R. Antar, Marissa K. Hetrich, et al.
The Journal of Infectious Diseases (2024)
Closed Access | Times Cited: 3
Nora Pisanic, Annukka A.R. Antar, Marissa K. Hetrich, et al.
The Journal of Infectious Diseases (2024)
Closed Access | Times Cited: 3
SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunity
Ninaad Lasrado, Marjorie Rowe, Katherine McMahan, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 770
Open Access | Times Cited: 2
Ninaad Lasrado, Marjorie Rowe, Katherine McMahan, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 770
Open Access | Times Cited: 2
Compartment-specific antibody correlates of protection to SARS-CoV-2 Omicron in macaques
Xin Tong, Qixin Wang, Wonyeong Jung, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110174-110174
Open Access | Times Cited: 1
Xin Tong, Qixin Wang, Wonyeong Jung, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110174-110174
Open Access | Times Cited: 1
A balance between innovation and biosafety
Stanley Perlman
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 29
Closed Access | Times Cited: 1
Stanley Perlman
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 29
Closed Access | Times Cited: 1
Enhancing immune defense against COVID-19: Alveolar delivery of mucosal vaccines
Pei-Huang Wu, Dong‐Chun Hong, Chu Xie, et al.
Science Bulletin (2024) Vol. 69, Iss. 23, pp. 3637-3639
Closed Access | Times Cited: 1
Pei-Huang Wu, Dong‐Chun Hong, Chu Xie, et al.
Science Bulletin (2024) Vol. 69, Iss. 23, pp. 3637-3639
Closed Access | Times Cited: 1
Germinal Center Response to mRNA Vaccination and Impact of Immunological Imprinting on Subsequent Vaccination
Wooseob Kim
Immune Network (2024) Vol. 24, Iss. 4
Open Access | Times Cited: 1
Wooseob Kim
Immune Network (2024) Vol. 24, Iss. 4
Open Access | Times Cited: 1
Antibodies as key mediators of protection against Mycobacterium tuberculosis
Qixin Wang, Deepika Nag, Susan L. Baldwin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Qixin Wang, Deepika Nag, Susan L. Baldwin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review of the Literature
Panagiota Tsagkli, Maria Geropeppa, Ioanna Papadatou, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1051-1051
Open Access | Times Cited: 1
Panagiota Tsagkli, Maria Geropeppa, Ioanna Papadatou, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1051-1051
Open Access | Times Cited: 1
Constructing the cGAMP‐Aluminum Nanoparticles as a Vaccine Adjuvant‐Delivery System (VADS) for Developing the Efficient Pulmonary COVID‐19 Subunit Vaccines
Ning Wang, Can Wang, Chunliu Wei, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 1
Ning Wang, Can Wang, Chunliu Wei, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 1
A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in mice
James Brett Case, Shilpa Sanapala, Carly Dillen, et al.
Cell Host & Microbe (2024)
Open Access | Times Cited: 1
James Brett Case, Shilpa Sanapala, Carly Dillen, et al.
Cell Host & Microbe (2024)
Open Access | Times Cited: 1